arrow
F

Floriana Camarda

Oncological Gynecology
H指数:10
被引数:490

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers

破译上皮性卵巢癌的脑转移: 多模态分析和潜在的生物标志物

2026-01-190
OAAI
Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancer

根据分子靶点临床可操作性量表(ESCAT)评估的,无特定分子特征(NSMP)子宫内膜癌的基因可操作性

2025-09-030
OAAI
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism

评估Khorana评分和基因组分析在卵巢癌相关静脉血栓栓塞中的预测作用

2025-02-010
PRE
Deep Dive Into No Specific Molecular Profile (NSMP) Endometrial Cancer: Unraveling Genomic Features According To Estrogen Receptor (ER) Expression

深入探讨无特定分子谱(NSMP)子宫内膜癌:根据雌激素受体(ER)表达解析基因组特征

2025-02-010
PRE
Management Of A Patient With Ovarian Cancer Carried Of The BRCA2 P.R3052Q Variant: From Tissue To Liquid Biopsy To Clarify The Molecular Status Of The Patient

携带BRCA2 P.R3052Q变异的卵巢癌患者管理:从组织活检到液体活检,以明确患者的分子状态

2025-02-010
PRE
Comprehensive Genomic Profiling (CGP) In Epithelial Ovarian Cancer: Biomarker Prevalence Across Different Histotypes

上皮性卵巢癌中的综合基因组分析(CG P):不同组织学类型的生物标志物流行率

2025-02-010
PRE
POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single-center cohort

子宫内膜癌中的POLE突变:来自大型前瞻性单中心队列的临床与基因组特征

CANCER
IF5.1
2025-01-250
OAAI
A monocentric analysis of ESCAT gene actionability detection in non-specific molecular profile (NSMP) early-stage endometrial cancer

非特异性分子表型(NSMP)早期子宫内膜癌中ESCAT基因可操作性的单中心分析

2024-09-010
PRE
Digital spatial transcriptomic reveals different epithelial and immune cells signatures across endometriosis-related diseases: From simple ovarian endometriosis to ovarian cancer
2024-03-220
PRE
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
2023-05-1817
OAAI